Last 12 months
Inside the activity.
0 purchase rows · 19 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 3 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 3 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 8 |
| Sep 2026 | 0 | 5 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 07, 2026 Filed Mar 9, 2026 20:19 UTC |
Sousa BenChief Information Officer
|
Exercise / conversionCommon Stock · Derivative | 1,409 | $0.00 | $0.00 |
DisclosureSEC source: 0002013412-26-000001 · edgardoc.xml · derivative · entry 7 Sousa Ben · CIK 0002013412 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,732 Underlying: Common Stock · 1,409 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. F3 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. F4 · derivative.exercise_date: One third of the units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date. F5 · derivative.expiration_date: These are restricted stock units that fully vest 3 years from the grant date. Read SEC document |
| March 07, 2026 Filed Mar 9, 2026 20:19 UTC |
Sousa BenChief Information Officer
|
Tax withholdingCommon Stock | 782 | $132.00 | $103,224.00 |
DisclosureSEC source: 0002013412-26-000001 · edgardoc.xml · nonDerivative · entry 2 Sousa Ben · CIK 0002013412 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,106 Read SEC document |
| March 07, 2026 Filed Mar 9, 2026 20:19 UTC |
Sousa BenChief Information Officer
|
Exercise / conversionCommon Stock | 1,409 | $0.00 | $0.00 |
DisclosureSEC source: 0002013412-26-000001 · edgardoc.xml · nonDerivative · entry 1 Sousa Ben · CIK 0002013412 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,888 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. Read SEC document |
| March 07, 2026 Filed Mar 9, 2026 20:18 UTC |
Sanzone Virginia RuthVP, General Counsel
|
Exercise / conversionCommon Stock · Derivative | 2,348 | $0.00 | $0.00 |
DisclosureSEC source: 0001669639-26-000001 · edgardoc.xml · derivative · entry 7 Sanzone Virginia Ruth · CIK 0001669639 · VP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,075 Underlying: Common Stock · 2,348 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. F3 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. F4 · derivative.exercise_date: One third of the units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date. F5 · derivative.expiration_date: These are restricted stock units that fully vest 3 years from the grant date. Read SEC document |
| March 07, 2026 Filed Mar 9, 2026 20:18 UTC |
Sanzone Virginia RuthVP, General Counsel
|
Tax withholdingCommon Stock | 1,297 | $132.00 | $171,204.00 |
DisclosureSEC source: 0001669639-26-000001 · edgardoc.xml · nonDerivative · entry 2 Sanzone Virginia Ruth · CIK 0001669639 · VP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,507 Read SEC document |
| March 07, 2026 Filed Mar 9, 2026 20:18 UTC |
Sanzone Virginia RuthVP, General Counsel
|
Exercise / conversionCommon Stock | 2,348 | $0.00 | $0.00 |
DisclosureSEC source: 0001669639-26-000001 · edgardoc.xml · nonDerivative · entry 1 Sanzone Virginia Ruth · CIK 0001669639 · VP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,804 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. Read SEC document |
| March 07, 2026 Filed Mar 9, 2026 20:15 UTC |
Woolson DanielVP, GM-Infusion Capital
|
Exercise / conversionPerformance Shares · Derivative | 1,585 | $0.00 | $0.00 |
DisclosureSEC source: 0001698998-26-000001 · edgardoc.xml · derivative · entry 9 Woolson Daniel · CIK 0001698998 · VP, GM-Infusion Capital 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,170 Underlying: Common Stock · 1,585 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the PRSUs. F8 · derivative.exercise_date: One-third of the shares shall vest on each of the first, second, and third anniversaries of the grant date. The vested shares shall become exercisable if, during the term of the option, the closing price of the Company's common stock is equal to or more than one-hundred and thirty percent of the exercise price per share for thirty consecutive trading days. The appreciation must occur within four years from the grant date. F9 · derivative.expiration_date: Vesting of these performance stock units are subject to the satisfaction of both performance-based conditions and time-based criteria. If earned, these PRSUs vest on the first, second, and third year following the year of grant. Read SEC document |
| March 07, 2026 Filed Mar 9, 2026 20:15 UTC |
Woolson DanielVP, GM-Infusion Capital
|
Tax withholdingCommon Stock | 702 | $132.00 | $92,664.00 |
DisclosureSEC source: 0001698998-26-000001 · edgardoc.xml · nonDerivative · entry 2 Woolson Daniel · CIK 0001698998 · VP, GM-Infusion Capital 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,180 Read SEC document |
| March 07, 2026 Filed Mar 9, 2026 20:15 UTC |
Woolson DanielVP, GM-Infusion Capital
|
Exercise / conversionCommon Stock | 1,585 | $0.00 | $0.00 |
DisclosureSEC source: 0001698998-26-000001 · edgardoc.xml · nonDerivative · entry 1 Woolson Daniel · CIK 0001698998 · VP, GM-Infusion Capital 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,882 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 07, 2026 Filed Mar 9, 2026 20:14 UTC |
Voigtlander Christian B.Chief Operating Officer
|
Exercise / conversionCommon Stock · Derivative | 3,522 | $0.00 | $0.00 |
DisclosureSEC source: 0001727477-26-000001 · edgardoc.xml · derivative · entry 5 Voigtlander Christian B. · CIK 0001727477 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,044 Underlying: Common Stock · 3,522 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. F3 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. F4 · derivative.exercise_date: One third of the units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date. F5 · derivative.expiration_date: These are restricted stock units that fully vest 3 years from the grant date. Read SEC document |
| March 07, 2026 Filed Mar 9, 2026 20:14 UTC |
Voigtlander Christian B.Chief Operating Officer
|
Tax withholdingCommon Stock | 1,946 | $132.00 | $256,872.00 |
DisclosureSEC source: 0001727477-26-000001 · edgardoc.xml · nonDerivative · entry 2 Voigtlander Christian B. · CIK 0001727477 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,664 Read SEC document |
| March 07, 2026 Filed Mar 9, 2026 20:14 UTC |
Voigtlander Christian B.Chief Operating Officer
|
Exercise / conversionCommon Stock | 3,522 | $0.00 | $0.00 |
DisclosureSEC source: 0001727477-26-000001 · edgardoc.xml · nonDerivative · entry 1 Voigtlander Christian B. · CIK 0001727477 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,610 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. Read SEC document |
| November 25, 2025 Filed Nov 25, 2025 20:18 UTC |
Woolson DanielVP, GM-Infusion Capital
|
SaleCommon Stock | 2,897 | $152.35 | $441,364.32 |
DisclosureSEC source: 0001698998-25-000004 · edgardoc.xml · nonDerivative · entry 1 Woolson Daniel · CIK 0001698998 · VP, GM-Infusion Capital 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,297 F1 · price: All shares sold were sold at the exact price disclosed. Read SEC document |
| November 11, 2025 Filed Nov 12, 2025 15:59 UTC |
FINNEY ELISHA WDirector
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 1,285 | $0.00 Strike: $103.76 | $0.00 |
DisclosureSEC source: 0001217439-25-000004 · edgardoc.xml · derivative · entry 3 FINNEY ELISHA W · CIK 0001217439 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,285 shares Expires 2026-01-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 11, 2025 Filed Nov 12, 2025 15:59 UTC |
FINNEY ELISHA WDirector
|
SaleCommon Stock | 1,285 | $140.42 | $180,439.70 |
DisclosureSEC source: 0001217439-25-000004 · edgardoc.xml · nonDerivative · entry 2 FINNEY ELISHA W · CIK 0001217439 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,995 F1 · price: All shares sold were sold at the exact price disclosed. Read SEC document |
| November 11, 2025 Filed Nov 12, 2025 15:59 UTC |
FINNEY ELISHA WDirector
|
Exercise / conversionCommon Stock | 1,285 | $103.76 | $133,331.60 |
DisclosureSEC source: 0001217439-25-000004 · edgardoc.xml · nonDerivative · entry 1 FINNEY ELISHA W · CIK 0001217439 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,280 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 11, 2025 Filed Nov 12, 2025 15:55 UTC |
Sanzone Virginia RuthVP, General Counsel
|
SaleCommon Stock | 930 | $142.35 | $132,380.85 |
DisclosureSEC source: 0001669639-25-000007 · edgardoc.xml · nonDerivative · entry 1 Sanzone Virginia Ruth · CIK 0001669639 · VP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,456 F1 · price: All shares sold were sold at the exact price disclosed. Read SEC document |
| September 12, 2025 Filed Sep 15, 2025 22:53 UTC |
Jain VivekDirector · Chairman and CEO
|
GiftCommon Stock | 63,641 | $0.00 | $0.00 |
DisclosureSEC source: 0001410442-25-000009 · edgardoc.xml · nonDerivative · entry 2 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Indirect · by Trust Disclosed balance after: 152,339 F1 · balance_after: This transaction represented a gift of securities from the reporting person to two trusts for the benefit of family members, who share the same household. The reporting person disclaims beneficial ownership of the shares held by the trusts, and this report shall not be deemed as an admission that the reporting person is the beneficial owner of the trust's shares for purposes of Section 16 or for any other purpose. Read SEC document |
| September 12, 2025 Filed Sep 15, 2025 22:53 UTC |
Jain VivekDirector · Chairman and CEO
|
GiftCommon Stock | 63,641 | $0.00 | $0.00 |
DisclosureSEC source: 0001410442-25-000009 · edgardoc.xml · nonDerivative · entry 1 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 66,508 F1 · kind: This transaction represented a gift of securities from the reporting person to two trusts for the benefit of family members, who share the same household. The reporting person disclaims beneficial ownership of the shares held by the trusts, and this report shall not be deemed as an admission that the reporting person is the beneficial owner of the trust's shares for purposes of Section 16 or for any other purpose. Read SEC document |
| August 27, 2025 Filed Aug 27, 2025 21:51 UTC |
Greenberg David C.Director
|
PurchaseCommon Stock | 598 | $126.69 | $75,760.32 |
DisclosureSEC source: 0001645866-25-000003 · edgardoc.xml · nonDerivative · entry 2 Greenberg David C. · CIK 0001645866 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,960 F2 · price: The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $126.55 to $127.14, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4. Read SEC document |
| August 27, 2025 Filed Aug 27, 2025 21:51 UTC |
Greenberg David C.Director
|
PurchaseCommon Stock | 602 | $126.14 | $75,937.97 |
DisclosureSEC source: 0001645866-25-000003 · edgardoc.xml · nonDerivative · entry 1 Greenberg David C. · CIK 0001645866 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,362 F1 · price: The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $125.52 to $126.48, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4. Read SEC document |
| August 14, 2025 Filed Aug 14, 2025 23:07 UTC |
Jain VivekDirector · Chairman and CEO
|
PurchaseCommon Stock | 19,551 | $112.92 | $2,207,761.48 |
DisclosureSEC source: 0001410442-25-000008 · edgardoc.xml · nonDerivative · entry 2 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 130,149 F2 · price: The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $112.48 to $113.435, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4. Read SEC document |
| August 14, 2025 Filed Aug 14, 2025 23:07 UTC |
Jain VivekDirector · Chairman and CEO
|
PurchaseCommon Stock | 2,378 | $112.12 | $266,613.04 |
DisclosureSEC source: 0001410442-25-000008 · edgardoc.xml · nonDerivative · entry 1 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 110,598 F1 · price: The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $111.75 to $112.435 inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4. Read SEC document |
| May 30, 2025 Filed May 30, 2025 18:34 UTC |
Sanzone Virginia RuthVP, General Counsel
|
SaleCommon Stock | 700 | $133.62 | $93,537.08 |
DisclosureSEC source: 0001669639-25-000005 · edgardoc.xml · nonDerivative · entry 1 Sanzone Virginia Ruth · CIK 0001669639 · VP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,386 F1 · price: All shares sold were sold at the exact price disclosed. Read SEC document |
| May 28, 2025 Filed May 28, 2025 16:00 UTC |
Voigtlander Christian B.Chief Operating Officer
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 5,560 | $0.00 Strike: $96.83 | $0.00 |
DisclosureSEC source: 0001727477-25-000008 · edgardoc.xml · derivative · entry 6 Voigtlander Christian B. · CIK 0001727477 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,560 shares Expires 2025-06-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 28, 2025 Filed May 28, 2025 16:00 UTC |
Voigtlander Christian B.Chief Operating Officer
|
SaleCommon Stock | 4,985 | $128.50 | $640,576.49 |
DisclosureSEC source: 0001727477-25-000008 · edgardoc.xml · nonDerivative · entry 4 Voigtlander Christian B. · CIK 0001727477 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,088 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $128.50 to $128.54 inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| May 28, 2025 Filed May 28, 2025 16:00 UTC |
Voigtlander Christian B.Chief Operating Officer
|
Exercise / conversionCommon Stock | 5,560 | $96.83 | $538,374.80 |
DisclosureSEC source: 0001727477-25-000008 · edgardoc.xml · nonDerivative · entry 3 Voigtlander Christian B. · CIK 0001727477 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,073 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 27, 2025 Filed May 28, 2025 16:00 UTC |
Voigtlander Christian B.Chief Operating Officer
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 5,555 | $0.00 Strike: $96.83 | $0.00 |
DisclosureSEC source: 0001727477-25-000008 · edgardoc.xml · derivative · entry 5 Voigtlander Christian B. · CIK 0001727477 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,560 Underlying: Common Stock · 5,555 shares Expires 2025-06-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 27, 2025 Filed May 28, 2025 16:00 UTC |
Voigtlander Christian B.Chief Operating Officer
|
SaleCommon Stock | 4,945 | $131.00 | $647,795.00 |
DisclosureSEC source: 0001727477-25-000008 · edgardoc.xml · nonDerivative · entry 2 Voigtlander Christian B. · CIK 0001727477 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,513 F1 · price: All shares sold were sold at the exact price disclosed. Read SEC document |
| May 27, 2025 Filed May 28, 2025 16:00 UTC |
Voigtlander Christian B.Chief Operating Officer
|
Exercise / conversionCommon Stock | 5,555 | $96.83 | $537,890.65 |
DisclosureSEC source: 0001727477-25-000008 · edgardoc.xml · nonDerivative · entry 1 Voigtlander Christian B. · CIK 0001727477 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,458 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 23, 2025 Filed May 23, 2025 21:01 UTC |
Voigtlander Christian B.Chief Operating Officer
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 5,555 | $0.00 Strike: $96.83 | $0.00 |
DisclosureSEC source: 0001727477-25-000007 · edgardoc.xml · derivative · entry 6 Voigtlander Christian B. · CIK 0001727477 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,115 Underlying: Common Stock · 5,555 shares Expires 2025-06-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 23, 2025 Filed May 23, 2025 21:01 UTC |
Voigtlander Christian B.Chief Operating Officer
|
SaleCommon Stock | 4,959 | $130.00 | $644,670.00 |
DisclosureSEC source: 0001727477-25-000007 · edgardoc.xml · nonDerivative · entry 4 Voigtlander Christian B. · CIK 0001727477 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,903 F1 · price: All shares sold were sold at the exact price disclosed. Read SEC document |
| May 23, 2025 Filed May 23, 2025 21:01 UTC |
Voigtlander Christian B.Chief Operating Officer
|
Exercise / conversionCommon Stock | 5,555 | $96.83 | $537,890.65 |
DisclosureSEC source: 0001727477-25-000007 · edgardoc.xml · nonDerivative · entry 3 Voigtlander Christian B. · CIK 0001727477 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,862 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 22, 2025 Filed May 23, 2025 21:01 UTC |
Voigtlander Christian B.Chief Operating Officer
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 5,555 | $0.00 Strike: $96.83 | $0.00 |
DisclosureSEC source: 0001727477-25-000007 · edgardoc.xml · derivative · entry 5 Voigtlander Christian B. · CIK 0001727477 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,670 Underlying: Common Stock · 5,555 shares Expires 2025-06-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 22, 2025 Filed May 23, 2025 21:01 UTC |
Voigtlander Christian B.Chief Operating Officer
|
SaleCommon Stock | 4,959 | $130.03 | $644,832.16 |
DisclosureSEC source: 0001727477-25-000007 · edgardoc.xml · nonDerivative · entry 2 Voigtlander Christian B. · CIK 0001727477 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,307 F1 · price: All shares sold were sold at the exact price disclosed. Read SEC document |
| May 22, 2025 Filed May 23, 2025 21:01 UTC |
Voigtlander Christian B.Chief Operating Officer
|
Exercise / conversionCommon Stock | 5,555 | $96.83 | $537,890.65 |
DisclosureSEC source: 0001727477-25-000007 · edgardoc.xml · nonDerivative · entry 1 Voigtlander Christian B. · CIK 0001727477 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,266 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 21, 2025 Filed May 21, 2025 20:23 UTC |
Voigtlander Christian B.Chief Operating Officer
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 5,555 | $0.00 Strike: $96.83 | $0.00 |
DisclosureSEC source: 0001727477-25-000006 · edgardoc.xml · derivative · entry 6 Voigtlander Christian B. · CIK 0001727477 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,225 Underlying: Common Stock · 5,555 shares Expires 2025-06-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 21, 2025 Filed May 21, 2025 20:23 UTC |
Voigtlander Christian B.Chief Operating Officer
|
SaleCommon Stock | 4,917 | $133.00 | $653,961.00 |
DisclosureSEC source: 0001727477-25-000006 · edgardoc.xml · nonDerivative · entry 4 Voigtlander Christian B. · CIK 0001727477 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,711 F2 · price: All shares sold were sold at the exact price disclosed. Read SEC document |
| May 21, 2025 Filed May 21, 2025 20:23 UTC |
Voigtlander Christian B.Chief Operating Officer
|
Exercise / conversionCommon Stock | 5,555 | $96.83 | $537,890.65 |
DisclosureSEC source: 0001727477-25-000006 · edgardoc.xml · nonDerivative · entry 3 Voigtlander Christian B. · CIK 0001727477 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,628 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 20, 2025 Filed May 21, 2025 20:23 UTC |
Voigtlander Christian B.Chief Operating Officer
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 5,555 | $0.00 Strike: $96.83 | $0.00 |
DisclosureSEC source: 0001727477-25-000006 · edgardoc.xml · derivative · entry 5 Voigtlander Christian B. · CIK 0001727477 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,780 Underlying: Common Stock · 5,555 shares Expires 2025-06-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 20, 2025 Filed May 21, 2025 20:23 UTC |
Voigtlander Christian B.Chief Operating Officer
|
SaleCommon Stock | 4,871 | $137.11 | $667,878.88 |
DisclosureSEC source: 0001727477-25-000006 · edgardoc.xml · nonDerivative · entry 2 Voigtlander Christian B. · CIK 0001727477 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,073 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $136.92 to $137.27, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| May 20, 2025 Filed May 21, 2025 20:23 UTC |
Voigtlander Christian B.Chief Operating Officer
|
Exercise / conversionCommon Stock | 5,555 | $96.83 | $537,890.65 |
DisclosureSEC source: 0001727477-25-000006 · edgardoc.xml · nonDerivative · entry 1 Voigtlander Christian B. · CIK 0001727477 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,944 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 19, 2025 Filed May 19, 2025 21:28 UTC |
Voigtlander Christian B.Chief Operating Officer
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 5,555 | $0.00 Strike: $96.83 | $0.00 |
DisclosureSEC source: 0001727477-25-000004 · edgardoc.xml · derivative · entry 6 Voigtlander Christian B. · CIK 0001727477 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,335 Underlying: Common Stock · 5,555 shares Expires 2025-06-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 19, 2025 Filed May 19, 2025 21:28 UTC |
Voigtlander Christian B.Chief Operating Officer
|
SaleCommon Stock | 5,555 | $138.00 | $766,614.44 |
DisclosureSEC source: 0001727477-25-000004 · edgardoc.xml · nonDerivative · entry 4 Voigtlander Christian B. · CIK 0001727477 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,389 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $138.00 to $138.11, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in this Form 4. Read SEC document |
| May 19, 2025 Filed May 19, 2025 21:28 UTC |
Voigtlander Christian B.Chief Operating Officer
|
Exercise / conversionCommon Stock | 5,555 | $96.83 | $537,890.65 |
DisclosureSEC source: 0001727477-25-000004 · edgardoc.xml · nonDerivative · entry 3 Voigtlander Christian B. · CIK 0001727477 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,944 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 19, 2025 Filed May 20, 2025 15:48 UTC |
FINNEY ELISHA WDirector
|
SaleCommon Stock | 600 | $138.92 | $83,352.54 |
DisclosureSEC source: 0000950170-25-074978 · ownership.xml · nonDerivative · entry 1 FINNEY ELISHA W · CIK 0001217439 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,252 F1 · price: All shares sold were sold at the exact price disclosed. Read SEC document |
| May 16, 2025 Filed May 19, 2025 21:28 UTC |
Voigtlander Christian B.Chief Operating Officer
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 5,555 | $0.00 Strike: $96.83 | $0.00 |
DisclosureSEC source: 0001727477-25-000004 · edgardoc.xml · derivative · entry 5 Voigtlander Christian B. · CIK 0001727477 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,890 Underlying: Common Stock · 5,555 shares Expires 2025-06-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 16, 2025 Filed May 19, 2025 21:28 UTC |
Voigtlander Christian B.Chief Operating Officer
|
SaleCommon Stock | 5,555 | $140.00 | $777,700.00 |
DisclosureSEC source: 0001727477-25-000004 · edgardoc.xml · nonDerivative · entry 2 Voigtlander Christian B. · CIK 0001727477 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,389 F1 · price: All shares sold were sold at the exact price disclosed. Read SEC document |
| May 16, 2025 Filed May 19, 2025 21:28 UTC |
Voigtlander Christian B.Chief Operating Officer
|
Exercise / conversionCommon Stock | 5,555 | $96.83 | $537,890.65 |
DisclosureSEC source: 0001727477-25-000004 · edgardoc.xml · nonDerivative · entry 1 Voigtlander Christian B. · CIK 0001727477 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,944 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 15, 2025 Filed May 15, 2025 20:57 UTC |
Voigtlander Christian B.Chief Operating Officer
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 5,555 | $0.00 Strike: $96.83 | $0.00 |
DisclosureSEC source: 0001727477-25-000003 · edgardoc.xml · derivative · entry 6 Voigtlander Christian B. · CIK 0001727477 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,445 Underlying: Common Stock · 5,555 shares Expires 2025-06-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.